Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10683293
APP PUB NO 20170342074A1
SERIAL NO

15501226

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compounds active towards nuclear receptors, pharmaceutical compositions containing the compounds and use of the compounds in therapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NUEVOLUTION A/S2100 COPENHAGEN Ø

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Glad, Sanne Schrøder Ballerup, DK 8 77
Gouliaev, Alex Haahr Veksø Sjælland, DK 43 598
Nørager, Niels Grøn Copenhagen, DK 3 9
Sarvary, Ian Kristinehamn, SE 11 11
Stasi, Luigi Piero Søllerød, DK 33 77
Teuber, Lene Værløse, DK 64 330

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 16, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 16, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00